Filing Details

CUSIP No. 29405E109

13G

Page 2 of 5 Pages

1

NAMES OF REPORTING PERSONSI

Chex Associates, LLC 27-2949501

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(see instructions)

(a) [   ]

(b) [  ]

3

SEC USE ONLY

4

CITIZENSHIP OR PLACE OF ORGANIZATION

Delaware

NUMBER OF

SHARES

BENEFICIALLY

OWNED

BY EACH

REPORTING

PERSON WITH

5

SOLE VOTING POWER

882,790

6

SHARED VOTING POWER

7

SOLE DISPOSITIVE POWER

882,790

8

SHARED DISPOSITIVE POWER

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

882,790

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

(see instructions) [  ]

11

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

7.62

12

TYPE OF REPORTING PERSON (see instructions)

00

CUSIP No. 29405E109

13G

Page 3 of 5 Pages

(a)

Name of Issuer

ENVERIC BIOSCIENCES, INC.

(b)

Address of Issuer’s Principal Executive Offices

4851Tomiami Trail

Naples, FL 34103

(a)

Name of Person Filing

CHEX ASSOCIATES, LLC

(b)

Address of the Principal Office or, if none, residence

2917 Avenue I

Brooklyn, New York 11210

(c)

Citizenship

Delaware

(d)

Title of Class of Securities

Common Stock, Par Value $0.01 per share

(e)

CUSIP Number 29405E109

(a)

[   ]

Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).

(b)

[   ]

Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).

(c)

[   ]

Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c).

(d)

[   ]

Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).

(e)

[   ]

An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);

(f)

[   ]

An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);

(g)

[   ]

A parent holding company or control person in accordance with §240.13d-1(b)(1)(ii)(G);

(h)

[   ]

A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

(i)

[   ]

A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);

(j)

[   ]

Group, in accordance with §240.13d-1(b)(1)(ii)(J).

CUSIP No. 29405E109

13G

Page 4 of 5 Pages

(a)

Amount beneficially owned: 882,790

(b)

Percent of class: 7.62%

(c)

Number of shares as to which the person has:

(i)

Sole power to vote or to direct the vote 882,790

(ii)

Shared power to vote or to direct the vote

(iii)

Sole power to dispose or to direct the disposition of 882.790

(iv)

Shared power to dispose or to direct the disposition of

(a)

The following certification shall be included if the statement is filed pursuant to §240.13d-1(b):

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

CUSIP No. 29405E109

13G

Page 5 of 5 Pages

(b)

The following certification shall be included if the statement is filed pursuant to §240.13d-1(c):

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

January 12, 2021

Date

/s/ SOLOMON EISENBERG

Signature

SOLOMON EISENBERG, Manager

Name/Title